Disadvantages |
Potentially insufficient calendar time to complete therapy due to unpredictable timing of transplant
Difficulties in differentiating drug toxicity from signs/symptoms of underlying organ disease
Drug-induced liver injury could be fatal with preexisting advanced liver disease in liver transplant candidates
|
Possibly lower efficacy in setting of concurrent immunosuppression
Additional pill burden to an already complex medication regimen
Potentially severe drug interactions with immunosuppressants
Higher reported rate of drug-induced liver injury and discontinuation in liver graft recipients
Any elevation in liver function tests creates need for extensive evaluation including invasive procedures (eg, liver biopsy to rule out rejection)
|